Skip to main content
Premium Trial:

Request an Annual Quote

Novacyt Secures $5.5M Loan

NEW YORK — French diagnostics firm Novacyt said on Wednesday that it has signed an agreement for a €5.0 million ($5.5 million) secured loan.

The loan is being provided by Harbert European Growth Capital (HEGC). Under the terms of the deal, the four-year loan has a fixed 11 percent annual interest rate and HEGC will receive warrants for around 6 million shares of Novacyt, representing 8.5 percent of the principal loan amount.

Novacyt said the money will be used to repay €1.2 million in bonds under a 2016 deal with Kreos Capital; pay the balance of an €800,000 tied to its acquisition of PCR firm Primerdesign; and repay €900,000 in unconverted debt under a convertible bond facility signed with Negma Group. About  €2.0 million will go toward working capital.

"This new financing addresses the working capital constraints and also removes the requirement for further drawdowns of the dilutive Negma convertible bond facility," Novacyt CEO Graham Mullis said in a statement.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.